Hamps Bio Ltd Completes Acquisition of HSDL Innovative Private Limited for INR 2,04,00,000

Hamps Bio Ltd has announced the completion of the acquisition of 100% equity shares of HSDL Innovative Private Limited. The total purchase consideration for this acquisition is INR 2,04,00,000. This acquisition has resulted in HSDL Innovative Private Limited becoming a Wholly Owned Subsidiary of Hamps Bio Ltd. The acquisition was completed on 25th March 2026. The necessary information has been provided to the Stock Exchange(s) as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circular no. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026.